Sweden · Delayed Price · Currency is SEK Enzymatica AB Statistics
Total Valuation
Enzymatica AB has a market cap or net worth of SEK 628.68 million. The enterprise value is 635.79 million.
| Market Cap | 628.68M |
| Enterprise Value | 635.79M |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enzymatica AB has 242.74 million shares outstanding.
| Current Share Class | 242.74M |
| Shares Outstanding | 242.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.30% |
| Owned by Institutions (%) | 1.05% |
| Float | 175.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.21 |
| PB Ratio | 6.70 |
| P/TBV Ratio | 20.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.74 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -72.14 |
Financial Efficiency
Return on equity (ROE) is -36.11% and return on invested capital (ROIC) is -20.60%.
| Return on Equity (ROE) | -36.11% |
| Return on Assets (ROA) | -18.49% |
| Return on Invested Capital (ROIC) | -20.60% |
| Return on Capital Employed (ROCE) | -35.51% |
| Weighted Average Cost of Capital (WACC) | 1.38% |
| Revenue Per Employee | 3.03M |
| Profits Per Employee | -2.44M |
| Employee Count | 18 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.33 |
Taxes
In the past 12 months, Enzymatica AB has paid 597,000 in taxes.
| Income Tax | 597,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.90% in the last 52 weeks. The beta is -0.53, so Enzymatica AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.53 |
| 52-Week Price Change | +28.90% |
| 50-Day Moving Average | 1.90 |
| 200-Day Moving Average | 2.20 |
| Relative Strength Index (RSI) | 75.39 |
| Average Volume (20 Days) | 163,460 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Enzymatica AB had revenue of SEK 51.49 million and -41.46 million in losses. Loss per share was -0.17.
| Revenue | 51.49M |
| Gross Profit | 30.26M |
| Operating Income | -40.33M |
| Pretax Income | -40.86M |
| Net Income | -41.46M |
| EBITDA | -38.00M |
| EBIT | -40.33M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 6.69 million in cash and 13.80 million in debt, with a net cash position of -7.11 million or -0.03 per share.
| Cash & Cash Equivalents | 6.69M |
| Total Debt | 13.80M |
| Net Cash | -7.11M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 93.90M |
| Book Value Per Share | 0.39 |
| Working Capital | 27.08M |
Cash Flow
In the last 12 months, operating cash flow was -23.60 million and capital expenditures -164,000, giving a free cash flow of -23.76 million.
| Operating Cash Flow | -23.60M |
| Capital Expenditures | -164,000 |
| Depreciation & Amortization | 2.33M |
| Net Borrowing | -2.58M |
| Free Cash Flow | -23.76M |
| FCF Per Share | -0.10 |
Margins
Gross margin is 58.76%, with operating and profit margins of -78.33% and -80.52%.
| Gross Margin | 58.76% |
| Operating Margin | -78.33% |
| Pretax Margin | -79.36% |
| Profit Margin | -80.52% |
| EBITDA Margin | -73.81% |
| EBIT Margin | -78.33% |
| FCF Margin | n/a |
Dividends & Yields
Enzymatica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.59% |
| FCF Yield | -3.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |